
- /
- Supported exchanges
- / TO
Bausch Health Companies Inc (BHC TO) stock market data APIs
Bausch Health Companies Inc Financial Data Overview
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bausch Health Companies Inc data using free add-ons & libraries
Get Bausch Health Companies Inc Fundamental Data
Bausch Health Companies Inc Fundamental data includes:
- Net Revenue: 9 474 M
- EBITDA: 3 069 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-10-30
- EPS/Forecast: 1.06
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bausch Health Companies Inc News

Sector Update: Health Care Stocks Slide Late Afternoon
Health care stocks were lower late Thursday afternoon, with the NYSE Health Care Index down 0.8% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...


Bausch + Lomb Sale Stumble Frustrates Bausch Health Investors
(Bloomberg) -- Bausch Health Companies Inc.’s years-long process of trying to separate its Bausch + Lomb Corp. eye-care business hit a roadblock Thursday when a potential sale to private equity fell...

Bausch + Lomb Down 7% In US Premarket As Potential Sale Plans Shelved
Bausch + Lomb Corporation (NYSE and TSX: BLCO), a global eye health company, was at last look down 7 PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...

Contact lens maker Bausch + Lomb rules out going private at this time
(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday, sending its U.S.-listed shares down 7% to $16.50 in premarket trading. The company had said i...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.